» Articles » PMID: 38767984

Short-Term Use of Upadacitinib in Combination With Biologic Therapy for Inducing Clinical Remission in Patients With Active Inflammatory Bowel Disease

Overview
Specialty Gastroenterology
Date 2024 May 20
PMID 38767984
Authors
Affiliations
Soon will be listed here.
Citing Articles

Advanced Combination Therapy with Biologics and Upadacitinib in Refractory Inflammatory Bowel Disease: A Retrospective Study from Taiwan.

Meng M, Kuo C, Lai M, Chiu C, Su M, Chang M J Inflamm Res. 2025; 18:2733-2742.

PMID: 40026313 PMC: 11872097. DOI: 10.2147/JIR.S511309.